Phage Therapy Institute –

Research Theme

1. Construction of phage cocktail evaluation method
2. Preparation of broad-host range phage by evolutionary engineering
3. Preparation of synthetic phage that can avoid bacterial defense systems
4. Verification of phage therapy efficacy by animal experiments
5. Social implementation through industry-government-academia joint research
6. Resolution of issues for clinical application in collaboration with academic
associations, industry associations, regulatory authorities, and clinicians

Research Director

TSUNEDA, Satoshi

Faculty of Science and Engineering, School of Advanced Science and Engineering

 Research Director Database

Project Members

Researchers

ASAHI, Toru Professor, Faculty of Science and Engineering, School of Advanced Science and Engineering
INOUE, Takafumi Professor, Faculty of Science and Engineering, School of Advanced Science and Engineering
KANEKO, Tomoyoshi Research Associate, Faculty of Science and Engineering, School of Advanced Science and Engineering
NAKATSUKA, Kanata Research Associate, Faculty of Science and Engineering, School of Advanced Science and Engineering
OHSHIMA, Toshio Professor, Faculty of Science and Engineering, School of Advanced Science and Engineering
TAKEYAMA, Haruko Professor, Faculty of Science and Engineering, School of Advanced Science and Engineering
TSUNEDA, Satoshi Professor, Faculty of Science and Engineering, School of Advanced Science and Engineering

Guest Researcher / Adjunct Researcher

IWANO, Hidetomo
KIGA, Kotaro
KITAOKA, Kazuki
MIYANAGA, Kazuhiko
NAKAMURA, Tomohiro

 Research Keywords
 Research Summary
 Related Documents
 Contact

Research Keywords

bacterial infection, phage therapy, antibiotic-resistant bacteria, bacteriophage

Back to menu

Research Summary

The Phage Therapy Institute is the first institute in Japan to specialize in phage therapy research. We will conduct basic research on the construction of phage libraries and the characterization of phage. At the same time, we will form a consortium with other research institutions to extract technical and ethical issues in the clinical application of phage therapy and propose their solutions. Furthermore, we will conduct industry-government-academia projects related to phage therapy, organize international and domestic symposiums, and conduct academic exchanges with European, American, and Asian countries.

Back to menu